Literature DB >> 26429417

Serum Zinc Concentration and C-Reactive Protein in Individuals with Human Immunodeficiency Virus Infection: the Positive Living with HIV (POLH) Study.

Krishna C Poudel1, Elizabeth R Bertone-Johnson2, Kalpana Poudel-Tandukar3.   

Abstract

Low zinc levels and chronic inflammation are common in individuals infected with human immunodeficiency virus (HIV). Zinc deficiency may promote systemic inflammation, but research on the role of zinc in inflammation among HIV-positive individuals taking account of anti-retroviral therapy is lacking. We assessed the association between serum zinc and C-reactive protein (CRP) concentration in a cohort of HIV-positive individuals. A cross-sectional survey was conducted among 311 HIV-positive individuals (177 men and 134 women) aged 18-60 years residing in Kathmandu, Nepal. High-sensitive or regular serum CRP concentrations were measured by the latex agglutination nephelometry or turbidimetric method, and zinc concentrations were measured by the atomic absorption method. Relationships were assessed using multiple linear regression analysis. The geometric means of zinc in men and women were 73.83 and 71.93 ug/dL, respectively, and of CRP were 1.64 and 0.96 mg/L, respectively. Mean serum CRP concentration was significantly decreased with increasing serum zinc concentration across zinc tertiles (P for trend = 0.010), with mean serum CRP concentration in the highest tertile of serum zinc concentration was 44.2 % lower than that in the lowest tertile. The mean serum CRP concentrations in men and women in the highest tertile of serum zinc concentrations were 30 and 35.9 % lower, respectively, than that in the lowest tertile (P for trend = 0.263 and 0.162, respectively). We found a significant inverse relation between log zinc and log CRP concentrations (beta for 1 unit change in log zinc; β = -1.79, p = 0.0003). Serum zinc concentration may be inversely associated with serum CRP concentration in HIV-positive individuals.

Entities:  

Keywords:  C-reactive protein; HIV infection; Inflammation; Nepal; Zinc

Mesh:

Substances:

Year:  2015        PMID: 26429417     DOI: 10.1007/s12011-015-0520-3

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  5 in total

1.  Design of a randomized controlled trial of zinc supplementation to improve markers of mortality and HIV disease progression in HIV-positive drinkers in St. Petersburg, Russia.

Authors:  Natalia Gnatienko; Matthew S Freiberg; Elena Blokhina; Tatiana Yaroslavtseva; Carly Bridden; Debbie M Cheng; Christine E Chaisson; Dmitry Lioznov; Sally Bendiks; Glory Koerbel; Sharon M Coleman; Evgeny Krupitsky; Jeffrey H Samet
Journal:  HIV Clin Trials       Date:  2018-04-17

2.  Inflammation in Relation to Intensity and Duration of Cigarette Smoking Among People Living with HIV.

Authors:  Krishna C Poudel; Kalpana Poudel-Tandukar; Elizabeth R Bertone-Johnson; Penelope Pekow; Damon J Vidrine
Journal:  AIDS Behav       Date:  2020-09-28

3.  The Role of Zinc in Antiviral Immunity.

Authors:  Scott A Read; Stephanie Obeid; Chantelle Ahlenstiel; Golo Ahlenstiel
Journal:  Adv Nutr       Date:  2019-07-01       Impact factor: 8.701

4.  Multiple plasma metals, genetic risk and serum C-reactive protein: A metal-metal and gene-metal interaction study.

Authors:  Yu Yuan; Pinpin Long; Kang Liu; Yang Xiao; Shiqi He; Jun Li; Tingting Mo; Yiyi Liu; Yanqiu Yu; Hao Wang; Lue Zhou; Xuezhen Liu; Handong Yang; Xiulou Li; Xinwen Min; Ce Zhang; Xiaomin Zhang; An Pan; Meian He; Frank B Hu; Ana Navas-Acien; Tangchun Wu
Journal:  Redox Biol       Date:  2019-12-10       Impact factor: 11.799

5.  Delays in antiretroviral therapy initiation among HIV-positive individuals: results of the positive living with HIV study.

Authors:  Krishna C Poudel; David R Buchanan; Kalpana Poudel-Tandukar
Journal:  Glob Health Action       Date:  2016-06-30       Impact factor: 2.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.